PMA device
Neuspera Sacral Neuromodulation (SNM) System
Neuspera Medical, Inc. · Stimulator, Electrical, Implantable, For Incontinence (EZW, Class III) · First FDA decision Jun 17, 2025, newest Apr 21, 2026Fecal incontinence and constipationOveractive bladder and urinary incontinence
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
PMA pathway
Device trials
79
Naming "Sacral Neuromodulation"
MAUDE reports
0
Brand "Sacral Neuromodulation", since 2015
PubMed studies
1,486
Mentioning "Sacral Neuromodulation"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Neuspera Sacral Neuromodulation (SNM) System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 3 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Non-Implantable Pelvic Floor Electrical StimulatorNational determinationOn the books230.8Updated Aug 17, 2023
- Pelvic Floor Electrical Stimulation for Urinary IncontinenceNational analysisReview closedCAG-00021NUpdated Sep 15, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "Sacral Neuromodulation", any status and sponsor, newest update first.
Axonics, Inc.Not on our public-company list
NCT07335484 · 75 participants (planned) · Start Apr 30, 2026 · Primary completion Nov 2026
Device: Axonics External Trial System (ETS) · For: Urinary Urge Incontinence (UUI); Urinary Frequency (UF); Fecal Incontinence (FI) and 1 more
Sites: Birmingham, Alabama; Macon, Georgia; Chicago, Illinois · 6 sites in all
- Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal IncontinenceRecruiting
Axonics, Inc.Not on our public-company list
NCT07499258 · 55 participants (planned) · Start Jul 2, 2026 · Primary completion Aug 2027
Device: Axonics SNM System INS Model 5101 (R20) · For: Fecal Incontinence
Sites: New York, New York; Cincinnati, Ohio; Nashville, Tennessee · 6 sites in all
Axonics, Inc.Not on our public-company list
NCT06511141 · 150 participants (planned) · Start Oct 22, 2024 · Primary completion Dec 2027
Device: Axonics SNM System · For: Overactive Bladder; Urinary Urgency Incontinence; Benign Prostatic Hyperplasia and 3 more
Sites: Birmingham, Alabama; Fairhope, Alabama; Scottsdale, Arizona · 23 sites in all
76 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Sacral Neuromodulation", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code EZW
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Sacral Neuromodulation"[tiab]. The summary above synthesizes these.
- [Anal incontinence].
Manegold P, Herold A · Chirurg · 2022
- Neuromodulation.
Noblett K, Crowder C · Obstet Gynecol Clin North Am · 2021Review
- Overactive Bladder.
White N, Iglesia CB · Obstet Gynecol Clin North Am · 2016Review
- Controversies in fecal incontinence.
Albuquerque A, Rao SSC · World J Gastroenterol · 2025Editorial
- Sacral neuromodulation in children and adolescents with defecation disorders.
Besendörfer M, Knorr C, Kirchgatter A, et al. · Neurogastroenterol Motil · 2024Multicenter Study
- Coding for Sacral Neuromodulation.
Muñoz JM, Davidson ERW · Urogynecology (Phila) · 2025
- Sacral neuromodulation: troubleshooting needle placement.
Hendrickson WK, Amundsen CL · Int Urogynecol J · 2021Video-Audio Media
- Sacral Neuromodulation: Mechanism of Action.
De Wachter S, Vaganee D, Kessler TM · Eur Urol Focus · 2020Review
- What Is New in Neuromodulation?
Moore CK, Rueb JJ, Derisavifard S · Curr Urol Rep · 2019Review
- Sacral neuromodulation - when and for who.
Mass-Lindenbaum M, Calderón-Pollak D, Goldman HB, et al. · Int Braz J Urol · 2021Editorial
- Sacral Neuromodulation: Device Improvement and Current Applications in Urology.
Spilotros M, Gerbasi S, Lasorsa F, et al. · Medicina (Kaunas) · 2024Review
- [Therapeutic value of neuromodulation in women].
van Ophoven A · Urologie · 2023English Abstract, Review
Other devices of this type
Also filed under product code EZW.
- InterStim Therapy System, Verify Evaluation SystemMedtronic Neuromodulation · PMA 2025
- Axonics Sacral Neuromodulation SystemBoston Scientific Corporation · PMA 2026
- InterStim® Sacral Nerve Stimulation Therapy System (Urinary Control )Medtronic Neuromodulation · PMA 2018
- Master InterStim® Therapy System, Verify® Evaluation SystemMedtronic Neuromodulation · PMA 2022
- Interstim SystemMedtronic Neuromodulation · PMA 2011
- Medtronic Interstim Tined Lead Models 3889 & 3093Medtronic Neuromodulation · PMA 2007
- Virtis Sacral Neuromodulation SystemCirtec Medical Corporation · PMA 2023
- Verify Evaluation System for Interstim Therapy for Urinary Control and Bowel ControlMedtronic Neuromodulation · PMA 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.